InvestorsHub Logo
Followers 2
Posts 26
Boards Moderated 0
Alias Born 07/19/2018

Re: None

Wednesday, 01/08/2020 7:16:09 AM

Wednesday, January 08, 2020 7:16:09 AM

Post# of 59550
Grapefruit/IGNG Announces Successful Results in Initial Tests for Efficacy of its Patented Time-Release THC Cannabinoid “Patchless Patch™”

1/8/20, 6:00 AM
Los Angeles/Desert Hot Springs, CA, Jan. 08, 2020 (GLOBE NEWSWIRE) -- Grapefruit Boulevard Investments, Inc., (“GBI”) a California based cannabis company and a wholly owned subsidiary of Imaging3, Inc., a Delaware corporation (“IGNG”) (OTCQB: IGNG) (collectively “Grapefruit” or the “Company”) is announcing today that the initial round of laboratory testing of the time release efficacy of its patented THC “Patchless Patch™” topical cream yielded successful results. The testing was performed using the Method described under United States Pharmacopeia Chapter 1724, commonly known as “Utilization of a Vertical Franz Diffusion Cell” in conjunction with a PVDF membrane, pore size of 0.2 µm. The use of a Franz diffusion cell to assess skin permeability is a well-recognized in vitro release-testing research methodology that provides key insights into the relationships between skin, drug and formulation.1 This particular Method was used to simulate the absorption rate of THC Cannabinoids through human skin. The THC Cannabinoids that crossed the membrane were measured at various time points using HPLC or High Performance Liquid Chromatography. The results demonstrate that Grapefruit’s THC Patchless Patch is able to deliver a consistent and predictable pre-defined dose of THC through a user’s skin over an approximate ten hour period of time.

With respect to the testing results of the Patchless Patch time-release mechanism, Bradley J. Yourist, Grapefruit CEO, stated, “the results of these tests of Grapefruit’s patented THC Cannabinoid time-release Patchless Patch have demonstrated its efficacy. Grapefruit believes that the consistent and sustained delivery of THC Cannabinoids over a defined period has the potential to change the manner in which chronic long-term pain and other disorders are managed. It also has the potential to provide an alternative to the use of highly addictive opioids for the treatment of chronic pain. Our hope is that this potentially game-changing technology will allow people who suffer from chronic pain and other disorders to lead more active and productive lives. Furthermore, our THC Patchless Patch has obvious applications in the recreational cannabis context for use at events such as concerts and movies as well as transcontinental flights. We are targeting the end of the Second Quarter of 2020 to bring the product to market. We will keep our shareholders and the public apprised of further developments with the THC Patchless Patch as they occur.”

To learn more about Grapefruit’s THC Cannabinoid Patchless Patch, please visit our website at:
https://grapefruitblvd.com/grapefruits-patented-time-release-thc-patchless-patch-topical-cream/